Ralph Giacobbe analyst

Currently out of the existing stock ratings of Ralph Giacobbe, 83 are a HOLD (30.29%), 186 are a BUY (67.88%), 5 are a SELL (1.82%).

Ralph Giacobbe

Work Performance Price Targets & Ratings Chart

Analyst Ralph Giacobbe, carries an average stock price target met ratio of 73.47% that have a potential upside of 22.49% achieved within 323 days. Previously, Ralph Giacobbe worked at CITI, CREDIT SUISSE.

Ralph Giacobbe’s has documented 501 price targets and ratings displayed on 31 stocks. The coverage was on Healthcare, Industrials, Communication Services sectors.

Most recent stock forecast was given on CANO, Cano Health at 11-Aug-2023.

Wall Street Analyst Ralph Giacobbe

Analyst best performing recommendations are on AGTI (AGILITI).
The best stock recommendation documented was for AGTI (AGILITI) at 5/18/2021. The price target of $19 was fulfilled within 7 days with a profit of $3.81 (25.08%) receiving and performance score of 35.83.

Average potential price target upside

ACHC Acadia Healthcare Company ANTM Anthem APR Apria BHG Bright Health Group CI Cigna Corp CLOV Clover Health Investments Corp CNC Centene Corp CVS CVS Health Corp CYH Community Health Systems DGX Quest Diagnostics EVHC Envision Healthcare Holdings HCA HCA Holdings HUM Humana LH Laboratory of America Holdings MD Mednax ONEM 1Life Healthcare PGNY Progyny SGRY Surgery Partners THC Tenet Healthcare UHS Universal Health Services UNH UnitedHealth Group WBA Walgreens Boots Alliance AGTI Agiliti INNV InnovAge Holding Corp CANO Cano Health ELV Elevance Health AG First Majestic Silver Corp AP Ampco-Pittsburgh ATI Allegheny Technologies LHCG LHC Group WB Weibo Corp

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 09-Apr-2025

$39

$10.87 (38.64%)

$38

Hold Since 03-Mar-2026

$32

$3.87 (13.76%)

$25

Buy Since 07-Jan-2025

$36

$7.87 (27.98%)

$30

Buy Since 05-Feb-2025

$40

$11.87 (42.20%)

$25

Buy Since 31-Jul-2023

$39

$10.87 (38.64%)

$31

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Ralph Giacobbe?

On 2008

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?